Return to work after gastric bypass in Medicaid-funded morbidly obese patients.

نویسندگان

  • Amy J Wagner
  • Joseph M Fabry
  • Richard C Thirlby
چکیده

OBJECTIVE To determine whether medically disabled (Medicaid-funded) morbidly obese patients return to the workforce after Roux-en-Y gastric bypass (RYGB). DESIGN Retrospective clinical data review. SETTING A tertiary referral center. PATIENTS From January 1, 1997, to December 31, 2002, 38 medically disabled patients underwent RYGB performed by a single surgeon. Sixteen medically disabled patients seen by the same surgeon did not undergo surgery and served as a control group. INTERVENTION Roux-en-Y gastric bypass. MAIN OUTCOME MEASURE Full-time employment. RESULTS The patients who underwent RYBG were more likely to return to work, with 14 (37%) working, compared with 1 (6%) of the nonoperative control patients (P = .02). Elimination of comorbidities was associated with a greater likelihood of return to work. Patients who had greater than the mean decrease in comorbid conditions at the time of follow-up were statistically more likely to return to work than those who did not have a reversal in comorbid conditions (P = .001). Health-related quality of life was very poor preoperatively and improved in all domains after surgery. CONCLUSIONS Morbid obesity is associated with many medical conditions that often render patients disabled. We found that 37% of morbidly obese patients with Medicaid coverage returned to work after RYGB, compared with 6% of patients in the nonoperative control group. This study suggests that RYGB, the most effective available means to achieve durable weight loss and reduction of comorbidities in morbidly obese patients, results in significant rehabilitation of Medicaid-funded morbidly obese individuals.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Vancomycin pharmacokinetics in normal and morbidly obese subjects.

In an uncontrolled study, vancomycin pharmacokinetics were determined in four normal (total body weight [TBW], 65.9 to 89.1 kg) and six morbidly obese (TBW, 111.4 to 226.4 kg) subjects. The morbidly obese subjects were investigated 3 to 4 h after gastric bypass surgery. Mean terminal half-lives, volumes of distribution, and total body clearances for the normal controls and the morbidly obese (T...

متن کامل

Safety and effectiveness of bariatric surgery: Roux-en-Y gastric bypass is superior to gastric banding in the management of morbidly obese patients

BACKGROUND The use of bariatric surgery in the management of morbid obesity is rapidly increasing. The two most frequently performed procedures are laparoscopic Roux-en-Y bypass and laparoscopic gastric banding. The objective of this short overview is to provide a critical appraisal of the most relevant scientific evidence comparing laparoscopic gastric banding versus laparoscopic Roux-en-Y byp...

متن کامل

Weight gain after short- and long-limb gastric bypass in patients followed for longer than 10 years.

OBJECTIVE To complete a long-term (>10 years) follow-up of patients undergoing isolated roux-en-Y gastric bypass for severe obesity. BACKGROUND Long-term results of gastric bypass in patients followed for longer than 10 years is not reported in the literature. METHODS Accurate weights were recorded on 228 of 272 (83.8%) of patients at a mean of 11.4 years (range, 4.7-14.9 years) after surge...

متن کامل

Liver markers, prevalence of the metabolic syndrome abnormalities and effect of Roux-en-Y gastric bypass in morbidly obese subjects.

OBJECTIVES To evaluate the relations between liver markers (GGT, ALT and AST) and the metabolic syndrome (and its components) in morbidly obese subjects, and to determine the response of these metabolic factors and hepatic enzymes after weight loss induced by Roux-en-Y gastric bypass. METHODS This study was carried out at a university hospital, in Santo André (SP), Brazil. We evaluated 140 mo...

متن کامل

Laparoscopic gastric bypass after cardiac transplantation.

c i d a Organ transplantation requires potent antirejection medcation that often results in significant weight gain [1]. vidence has shown that morbidly obese patients who unergo organ transplantation have significantly worse patient nd graft survival compared with morbidly obese patients ithout transplantation [2]. Permanent weight reduction in ransplanted morbidly obese patients is expected t...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Archives of surgery

دوره 142 10  شماره 

صفحات  -

تاریخ انتشار 2007